SpineGuard Reports 2019 Revenue of 6.8 M€

Regulatory News:

SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, reported today its preliminary unaudited consolidated full-year 2019 revenue, EBITDA and cash position.

Stéphane Bette, CEO and co-founder of SpineGuard, said: “In 2019 SpineGuard found its balance while affirming its strategic turn. The company reorganized in order to reach positive EBITDA and focus on innovation. We reduced significantly our commercial expenses toward historical products, whose sales were declining, and focused on our most recent products which are growing: the “smart” screw and the PediGuard Threaded. We kept investing in R&D in the robotic application of our DSG technology and the preparation for the launch of our new platform DSG Connect. These innovations are synergistic, value-creating and feed our search for strategic alliances with industry players in our sector. On those fundamentals, we are confident to reach our goals in 2020 on the financial front, but also commercially with the launch of a new generation of products and a strategic move in the field of robotics where we received marks of interest.”

€ thousands – IFRS	2019	2018	Variation
First quarter	1 648	1 769	-7%
Second quarter	1 797	1 857	-3%
Third quarter	1 721	1 879	-8%
Fourth quarter	1 663	2 070	- 19%
Full year	6 829	7 575	-10%

Unaudited

In total, 7,668 DSG embedded devices were sold in 2019, compared to 9,001 in 2018, a 15% decrease. We note however a stabilization of the quarterly revenue.

4,612 devices (60%) vs. 6,411 in 2018 (-14%) were sold in the United States, where the revenue was 6,446 KUS$ vs. 7,557 KUS$ in 2018, -15%.

Outside the United States, the revenue declined -8% at 1,072 K€ vs. 1,164 K€ in 2018. The full year consolidated revenue decreased -10% at current exchange rate (-14% in constant currency).